212 related articles for article (PubMed ID: 4921479)
1. Recent advances in the unerstanding and management of metabolic bone disease.
Smith R
Proc R Soc Med; 1970 Sep; 63(9):931-4. PubMed ID: 4921479
[No Abstract] [Full Text] [Related]
2. Calcium metabolism--recent advances.
Raisz LG
Dis Mon; 1972 Dec; ():1-56. PubMed ID: 4264562
[No Abstract] [Full Text] [Related]
3. The pharmacology of bone.
Raisz LG
Ration Drug Ther; 1971 Jun; 5(6):1-7. PubMed ID: 5565260
[No Abstract] [Full Text] [Related]
4. Physiological changes in metabolic disorders of bone and evaluation of agents used in their treatment.
Yasumura S
Semin Drug Treat; 1972; 2(1):1-13. PubMed ID: 4340203
[No Abstract] [Full Text] [Related]
5. The ageing skeleton.
Corless D
Practitioner; 1981 Dec; 225(1362):1775-85. PubMed ID: 7335609
[No Abstract] [Full Text] [Related]
6. Osteoporosis, osteomalacia, rickets, and Paget's disease.
Nugent CA; Gall EP; Pitt MJ
Prim Care; 1984 Jun; 11(2):353-68. PubMed ID: 6236469
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in the medical management of metabolic bone disease.
Henley JW; Ibbertson HK
Drugs; 1974; 8(4):246-9. PubMed ID: 4375558
[No Abstract] [Full Text] [Related]
8. Calcitonin 1970: review of recent developments.
MartÃnez Rovira GR
Bol Asoc Med P R; 1970 Apr; 62(4):107-14. PubMed ID: 4921872
[No Abstract] [Full Text] [Related]
9. Management of metabolic bone disease.
Br Med J; 1969 Mar; 1(5644):621-3. PubMed ID: 5766131
[No Abstract] [Full Text] [Related]
10. Bone disease in the elderly.
Smith R
Proc R Soc Med; 1976 Dec; 69(12):925-6. PubMed ID: 1013134
[No Abstract] [Full Text] [Related]
11. Histological effects of calcitonin in bone diseases.
Olah AJ; Dambacher M; Haas HG
Calcif Tissue Res; 1970; ():Suppl:154. PubMed ID: 5427964
[No Abstract] [Full Text] [Related]
12. Disorders of bone.
Chalmers GL
Practitioner; 1978 May; 220(1319):711-21. PubMed ID: 662803
[No Abstract] [Full Text] [Related]
13. [Calcium metabolism study performed by means of Ca-45 in bone diseases and idiopathic hypercalciuria].
Renier JC; Bernat M; Jallet P; Gillabert J; Boasson M; Milonas J; Audran M
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):699-706. PubMed ID: 7455604
[TBL] [Abstract][Full Text] [Related]
14. [Current problems of azotemic bone diseases].
Schaefer K; Opitz A
Dtsch Med Wochenschr; 1970 Jan; 95(2):84-8. PubMed ID: 4902985
[No Abstract] [Full Text] [Related]
15. Metabolic bone disease: a review.
Hamdy RC
J Tenn Med Assoc; 1988 May; 81(5):293-6. PubMed ID: 3290575
[No Abstract] [Full Text] [Related]
16. [Regulation of bone metabolism and metabolic bone diseases].
Baleva R
Vutr Boles; 1977; 16(3):8-14. PubMed ID: 197716
[No Abstract] [Full Text] [Related]
17. The treatment of metabolic bone disease.
Posen S; Clifton-Bligh P; Mason RS
Drugs; 1979 Apr; 17(4):297-302. PubMed ID: 456294
[No Abstract] [Full Text] [Related]
18. Osteoporosis and osteomalacia.
Russell LA
Rheum Dis Clin North Am; 2010 Nov; 36(4):665-80. PubMed ID: 21092845
[TBL] [Abstract][Full Text] [Related]
19. Delayed strontium absorption in post-menopausal osteoporosis and osteomalacia.
Gutteridge DH; Robinson CJ; Joplin GF
Clin Sci; 1968 Apr; 34(2):351-63. PubMed ID: 5653693
[No Abstract] [Full Text] [Related]
20. Skeletal renewal and metabolic bone disease.
Harris WH; Heaney RP
N Engl J Med; 1969 Feb; 280(6):303-11 concl. PubMed ID: 4302928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
